Insights into the antibacterial mechanism of PEGylated nano-bacitracin A against Streptococcus pneumonia: both penicillin-sensitive and penicillin-resistant strains [Corrigendum]
Open Access
- 1 January 2019
- journal article
- correction
- Published by Taylor & Francis Ltd in International Journal of Nanomedicine
- Vol. ume 14, 337-338
- https://doi.org/10.2147/IJN.S197963
Abstract
Insights into the antibacterial mechanism of PEGylated nano-bacitracin A against Streptococcus pneumonia: both penicillin-sensitive and penicillin-resistant strains [Corrigendum] Insights into the antibacterial mechanism of PEG ylated nano-bacitracin A against Streptococcus pneumonia: both penicillin-sensitive and penicillinresistant strains [Corrigendum]Hong W, Liu L, Zhang Z, Zhao Y, Zhang D, Liu M. Int J Nanomedicine. 2018;13:6297–6309.The author wishes to advise that on page 6306, Figure 7 parts A and B are incorrect. The correct figure parts are included below:Read the original articleThis publication has 1 reference indexed in Scilit:
- Insights into the antibacterial mechanism of PEGylated nano-bacitracin A against Streptococcus pneumonia: both penicillin-sensitive and penicillin-resistant strainsInternational Journal of Nanomedicine, 2018